Newsletter
Sign Up And Receive Our Latest Promotions!
Thank you! Your submission has been received!
.svg){kind=small}
DISCOVERY CORe®
ELEVATE YOUR RESEARCH ANALYSIS AND BUILD A KNOWLEDGE NETWORK
RetinAI Discovery CORE®
RetinAI Discovery CORE is a platform designed to enhance your research analysis by providing you with access to AI for OCT data and the ability to share data in a secure and collaborative way.
CORE benefits physicians and researchers by accelerating research analysis efficiently and at scale.
The platform quantifies endpoints and biomarkers automatically to quickly define patient subgroups.
In addition to AI, CORE offers users the ability to annotate images and capture new findings with electronic case report forms (eCRFs) in a digitalized environment. With CORE’s collaborative features, the platform supports the creation and evaluation of registries, real-world evidence databases and the ability to train other peers for best practices.
Discovery CORE is a cloud-based platform that is GDPR and HIPAA-compliant and is a single environment for real-time visibility and centralization of data. Discovery CORE accepts multiple data formats across imaging and medical data. The compatible formats include DICOM-compliant, .e2e, .fda, jpeg, png, pdf.
Discovery CORE is your powerful technology partner for data analysis and network-building on insights to expand your research reach in Ophthalmology.
CORE benefits physicians and researchers by accelerating research analysis efficiently and at scale.
The platform quantifies endpoints and biomarkers automatically to quickly define patient subgroups.
In addition to AI, CORE offers users the ability to annotate images and capture new findings with electronic case report forms (eCRFs) in a digitalized environment. With CORE’s collaborative features, the platform supports the creation and evaluation of registries, real-world evidence databases and the ability to train other peers for best practices.
Discovery CORE is a cloud-based platform that is GDPR and HIPAA-compliant and is a single environment for real-time visibility and centralization of data. Discovery CORE accepts multiple data formats across imaging and medical data. The compatible formats include DICOM-compliant, .e2e, .fda, jpeg, png, pdf.
Discovery CORE is your powerful technology partner for data analysis and network-building on insights to expand your research reach in Ophthalmology.
See how Discovery CORE can help your research.
Sign up now and receive a 2 months free trial to Discovery CORE and AI.
Sign up now and receive a 2 months free trial to Discovery CORE and AI.
KNOWLEDGE-CREATING FEATURES
- Instantly invite collaborators to access data you want to share → organize workbooks, set permissions, restrict data visibility.
CORE is cloud-based for global networking and collaboration. - Generate and centralize multi-dimensional insights → automatically enrich your OCT data (.dcm, .e2e., .fda files) with AI for data analysis at scale. Perform side-by-side comparisons across OCT images and fundus images. Customize eCRFs and use annotation tools for collecting new insights on top of AI findings.
- Registry building → use CORE to build a registry and share it with a network of researchers and collaborators. Work with RetinAI to bring it to the Ophthalmology community for global reach to advance knowledge.
Discovery CORE in action
The following picture provides a glimpse into the Discovery CORE platform.
Features displayed here include the overlay of AI on OCT images to visualize fluid and layers, side-by-side image comparisons on two different time points or visits, and progression plots of retinal fluid volume of a patient over time.
Features displayed here include the overlay of AI on OCT images to visualize fluid and layers, side-by-side image comparisons on two different time points or visits, and progression plots of retinal fluid volume of a patient over time.
SECURITY GUARANTEED
- CE-marked and FDA-cleared medical and imaging data management platform
- ISO certified
- GDPR and HIPAA-compliance
AI Features as Add-ons
AI models can be added on to Discovery CORE to provide measures at scale on datasets for retinal fluid volumes and thickness across multiple layers. Additional AI add-ons include analysis of biomarkers and models for Geographic Atrophy (coming soon).
FLUID SEGMENTATION MODEL
Identifies and quantifies the volume of pathological fluid such as intraretinal fluid (IRF), subretinal fluid (SRF) and pigment epithelium detachment (PED).
LAYER SEGMENTATION MODEL
MEASURES TOTAL RETINAL AND LAYER THICKNESS FOR THE FOLLOWING LAYERS:
Retinal Nerve Fiber Layer (RNFL; Ganglion Cell Layer (GCL) + Inner Plexiform Layer (IPL); Inner Nuclear Layer (INL) + Outer Plexiform Layer (OPL); Outer Nuclear Layer (ONL); Photoreceptor (PR) + Retinal Pigment Epithelium (RPE; and Choriocapillaris (CC) + Choroidal Stroma (CS).
Fluid and layer segmentation are CE-marked in the E.U. Research Use Only in other jurisdictions.
Take a tour of Discovery CORE and its AI features
Are you interested in having your data processed by AI for accelerated analysis?
Are you working on defining best practices with a group of collaborators?
Are you building a registry and you want to increase participation and insights?
Try Discovery CORE and its AI models for fluid and layer segmentation for a limited time offer of two months free if you sign up now.
FAQ
How long is the free trial?
You will have 2 months free access to Discovery CORE and AI models for layer and fluid segmentation. After this period, you will have the option to sign up for a paid subscription.
What are the benefits for joining this trial?
Gain early experience with an innovative technology platform and enhance data collaboration across clinics, research, studies. Help elevate your data analysis workflows for better data-driven decisions.
Can I share the invitation with a colleague who I think will be interested in participating?
Absolutely. Please do share information on the free trial of Discovery CORE and its AI models with any healthcare provider you think may be interested in accessing this free trial.
*Disclaimer
RetinAI Discovery® and the AI models are CE-Marked medical devices according to the Medical Devices Directive 93/42/EEC.
RetinAI Discovery® is a 510(k) FDA Cleared medical device in US.
RetinAI Discovery® and Retinai® are both trademarks of RetinAI Medical AG.
Discovery and AI Models are CE-Marked medical devices since April 2020 & December 2020 respectively.
